Lise Lund Kjems
Net worth: 21 998 $ as of 29/04/2024
Profile
Lise Lund Kjems served as the Vice President & Head-Clinical Development at Albireo Pharma, Inc. He then worked as the Chief Medical Officer at Cyclo Therapeutics, Inc. Dr. Kjems holds a doctorate degree from the University of Copenhagen.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
CYCLO THERAPEUTICS INC
0.06% | 06/03/2023 | 17,053 ( 0.06% ) | 21 998 $ | 29/04/2024 |
Former positions of Lise Lund Kjems
| Companies | Position | End |
|---|---|---|
| CYCLO THERAPEUTICS, INC. | Chief Tech/Sci/R&D Officer | 31/03/2023 |
| ALBIREO PHARMA, INC. | Corporate Officer/Principal | - |
Training of Lise Lund Kjems
| University of Copenhagen | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 1 |
|---|---|
| CYCLO THERAPEUTICS, INC. | Health Technology |
| Private companies | 1 |
|---|---|
Albireo Pharma, Inc.
 Albireo Pharma, Inc. Pharmaceuticals: MajorHealth Technology Albireo Pharma, Inc. is a clinical stage biopharmaceutical company, which engages in the development and commercialization of novel bile acid modulators for the treatment of orphan pediatric liver diseases and gastrointestinal disorders. Its pipeline products include Odevixibat, A3384, and Elobixibat. The company was founded by Jan Peter Mattsson and Per-Göran Gillberg on December 8, 2003 and is headquartered in Boston, MA. | Health Technology |
- Stock Market
- Insiders
- Lise Lund Kjems